Heterozygous Individuals for AGXT and Kidney Stones

ConditionKidney Stone
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Alabama at Birmingham

About this trial

This study seeks to examine the effects of a heterozygous mutation of the AGXT gene in a stone forming population on endogenous oxalate production. Participants will consume a controlled low-oxalate diet and provide blood and urine samples to measure the amount of oxalate in their bodies. Subjects will then be administered an intravenous (IV) load of glycolate, providing additional blood and urine samples afterwards to measure any increase in oxalate levels.

Eligibility criteria

Qualifiers

at least 18 years of age

history of calcium oxalate stones

heterozygous mutation of the AGXT gene, as evidenced by results from the Invitae Nephrolithiasis Panel

willingness to comply with a controlled diet for five days

Disqualifiers

pregnant individuals

individuals who are currently breast feeding

Trial design

Treatments tested in this trial

  • Controlled Diet
  • Glycolate Administration

Treatment groups

4 Participants
are divided into 1 treatment group

Locations

This trial has no locations